Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Methotrexate is not an additional risk factor for interstitial lung disease in RA patients

Patients with rheumatoid arthritis (RA) often suffer from what is referred to as interstitial lung disease (ILD).